1-6 of 6
acute kidney disease
Close
Sort by
Journal Articles

Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US

Rafael Fonseca, MD, May Hagiwara, PhD, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Jacqueline Buchanan, Thomas Delea, MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2211.
https://doi.org/10.1182/blood-2019-123743
Published: 2019
Journal Articles

Burden of Disease Progression in Patients with Multiple Myeloma Who Have Received at Least One Line of Therapy in the US

May Hagiwara, PhD, Thomas Delea, MBA, MSIA, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Rafael Fonseca, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4754.
https://doi.org/10.1182/blood-2018-99-117230
Published: 2018
Journal Articles

Prevalence of T315I, Dasatinib-Specific Resistant Mutations (F317L, V299L, and T315A), and Nilotinib-Specific Resistant Mutations (P-loop and F359) at the Time of Imatinib Resistance in Chronic-Phase Chronic Myeloid Leukemia (CP-CML).

Michael W.N. Deininger, MD, Michael J. Mauro, Yousif Matloub, Ritwik Sinha, Lynn Ploughman, David Liu, Jerald Radich
Journal: Blood
Blood (2008) 112 (11): 3236.
https://doi.org/10.1182/blood.V112.11.3236.3236
Published: 2008
Journal Articles

Mutational Analysis of Chronic Phase Chronic Myeloid Leukemia (CMLCP) Clones Reveals Heightened BCR-ABL1 Genetic Instability in Patients Failing Sequential Imatinib and Dasatinib Therapy.

Alfonso QuintasCardama, MD, Don L. Gibbons, M.D., Ph.D., Hagop M. Kantarjian, MD, Moshe Talpaz, Nicholas Donato, PhD, Jorge Cortes, MD
Journal: Blood
Blood (2008) 112 (11): 2114.
https://doi.org/10.1182/blood.V112.11.2114.2114
Published: 2008
Journal Articles

Mutations within BCR-ABL1 295–312 Define a Novel Region Associated with Poor Prognosis in Patients with Chronic Myelogenous Leukemia (CML) Resistant to Imatinib.

Alfonso Quintás-Cardama, MD, Don L. Gibbons, M.D., Ph.D., Hagop Kantarjian, M.D., Moshe Talpaz, M.D., Jorge Cortes, M.D., Nicholas Donato, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1936.
https://doi.org/10.1182/blood.V110.11.1936.1936
Published: 2007
Journal Articles

Mutational Analysis of Chronic Myeloid Leukemia (CML) Clones Reveals Heightened BCR-ABL1 Genetic Instability and Wild-Type BCR-ABL1 Exhaustion in Patients Failing Sequential Imatinib and Dasatinib Therapy.

Alfonso Quintás-Cardama, MD, Don L. Gibbons, M.D., Ph.D., Hagop Kantarjian, M.D., Moshe Talpaz, M.D., Nick Donato, Ph.D., Jorge Cortes, M.D.
Journal: Blood
Blood (2007) 110 (11): 1938.
https://doi.org/10.1182/blood.V110.11.1938.1938
Published: 2007